PHARMAVEST ApS: Financial statements 2012
CVR: 26385180
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
PHARMAVEST ApS (CVR 26385180) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 1,641,777 and a net result of DKK 736,953. Equity in the 2012 report amounted to DKK 2,907,413. The solvency ratio was 79.9%.
- Gross Profit
- DKK 1,641,777
- Profit/Loss
- DKK 736,953
- Equity
- DKK 2,907,413
- Total Assets
- DKK 3,636,809
Official annual report
Keep an eye on PHARMAVEST ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of December 31, 2012, MJAKP2 I/S has stepped down as auditor of PHARMAVEST ApS.
About PHARMAVEST ApS
PHARMAVEST ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Frank Orluff Lydig Kristensen. The company is owned by FRANK LYDIG HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 812,233 and a net result of DKK -167,231 compared with DKK 271,222 the year before. Equity in the 2025 report amounted to DKK 4,349,573.